(IN BRIEF) ZEISS Medical Technology will present a range of new innovations at ASCRS 2026, focusing on improving ophthalmic workflows across cataract, refractive, and retinal care. The company will introduce new surgical tools compatible with the DORC EVA NEXUS system, … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Germany, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Ireland, Management, Marketing, Science, Technology
Tagged Advanced Workflow and Cloud Based Care Solutions Highlight ZEISS Innovation Strategy in Ophthalmology, AI healthcare, ASCRS 2026, cataract surgery, cloud healthcare, digital health, DORC EVA NEXUS, Dr Dan Haddad, Magnus Reibenspiess, medical devices, MicroSurgical Technology, ophthalmology technology, patient engagement, ZEISS CLINIC 360, ZEISS Collaborative Care, ZEISS Introduces Next Generation Cataract and Patient Engagement Technologies at ASCRS Conference, ZEISS IOLMaster 700, ZEISS Medical Technology, ZEISS VERACITY Surgery Planner, ZEISS VisioGen
(IN BRIEF) A major data-driven study from Aalborg University has found that missing periods of continuous glucose monitor use in people with diabetes are closely linked to poorer blood sugar control — and likely not random. Analyzing sensor data from … Read the full press release
Posted in Business, Denmark, Education, Healthcare, News, Science, Society, Technology
Tagged Aalborg University, blood sugar control, CGM sensors, continuous glucose monitoring, Denmark diabetes statistics, diabetes research, Diabetes Technology & Therapeutics, digital health tools, glycemic regulation, missing data impact, Morten Hasselstrøm Jensen, New Insights: Gaps in Glucose Monitoring May Mask Treatment Failures in Diabetes Patients, Novo Nordisk, patient engagement, personalized diabetes care, real-world evidence, sensor usage patterns, Simon Lebech Cichosz, Steno Diabetes Center North Jutland, type 1 diabetes, type 2 diabetes
(IN BRIEF) Released on 23 June 2025, Better Medicines gathers informed perspectives from patients, healthcare workers, researchers, industry professionals, and regulators across the UK to examine the entire lifecycle of medicines. Funded by the MRC and NIHR, the report finds … Read the full press release
Posted in Construction, Education, Industrial, Infrastructure & Utilities, Science, Technology, United Kingdom
Tagged Better Medicines report, clinical trials, Department of Pharmacology, Faculty of Health and Life Sciences, Hopkins Van Mil, Institute of Systems Molecular and Integrative Biology, Manchester Metropolitan University, Medical Research Council, medicines lifecycle, National Institute for Health and Care Research, patient engagement, polypharmacy, postcode lottery, prescribing continuity, shared decision-making, therapeutics, Therapeutics Innovation, University College London, University of Liverpool, Yellow Card scheme
(IN BRIEF) The Conference Forum has announced the 9th annual Patients as Partners® Europe event, scheduled for May 20-21, 2025, at the Royal National Hotel in London. This event offers a platform for pharma R&D and patient advocacy to discuss … Read the full press release
Posted in France, Healthcare, Marketing, Pharma & Biotech, Science, Switzerland, United Kingdom
Tagged Alfred Samuels, AstraZeneca, Azafaros, Beyza Klein, Biotech, Biotechnology Conference, Boehringer Ingelheim, Bre Bugbee-Barrett, Catherine Coulouvrat MD, Chiesi Farmaceutici SpA, clinical development, clinical operations, clinical research, clinical research enterprise, clinical trial, clinical trials, Conference Forum, decentralized clinical trials, Gisela Linthorst, GSK, Harry Verbunt, HTA/Regulatory requirements, Johnson & Johnson Innovative Medicine, Lea-Isabelle Proulx PhD, life post-cancer diagnosis, Marisa Minetti, Medicine Development, Patient Advocacy, patient engagement, patient engagement in drug development, patient experience, Patient Recruitment, Patient Retention, Patients as Partners, Patients as Partners Europe, Peter DiBiaso, pharma, Pharmaceutical Conference, Regeneron, research and development, Roche, Royal National Hotel, Sanofi, Temi Olonisakin MD, The Conference Forum, Valerie Bowling
(IN BRIEF) The Conference Forum has announced that the 7th annual European Patients as Partners® in Clinical Research conference will take place in London on June 12-13, 2023. The event will focus on achieving greater representation in clinical research, building … Read the full press release
Posted in Government, Healthcare, News, Non Profit, Pharma & Biotech, United Kingdom
Tagged 7th annual European Patients as Partners®, biotechnology, Boehringer Ingelheim, Center for BME Health, clinical development, clinical research, Clinical Research conference, clinical trials, Community Engagement, CSL Behring, Deirdre BeVard, Diversity in Clinical Research, drug development, government, Health Equity, Healthcare, Hospital, Lundbeck, Medicine Development, Medicine Lifestyle, Medicines Development, Novartis, Patient Advocacy, Patient Centricity, Patient Communities, patient engagement, Patient Perspective, Patient Recruitment, Patient Retention, Patient Voice, Patients as Partners, Pharmaceutical, research and development, Sanofi, The Conference Forum, Thistle Hotel Marble Arch, Valerie Bowling
(PRESS RELEASE) New York, NY, United States, 5-Jan-2022 — /EuropaWire/ — The Conference Forum announced the launch of the 6th annual EU Patients as Partners in Medicines Development conference to take place virtually on January 24-25th, 2022 GMT time. This … Read the full press release
Posted in Education, Healthcare, Internet & Online, News, Pharma & Biotech, Science, Technology
Tagged 6th annual EU Patients as Partners, AbbVie, Biotech, clinical development, clinical research, clinical trial, clinical trials, Conference, Conference Forum, data, dct, decentralized, DNA, EMD Serono, Gilead Sciences, GSK, INNOVATION, Ipsen, Janssen, Johnson & Johnson, Medicines Development, Merck KGaA, Michaela Dinboeck, MS trial, Noema Pharma, Novartis, Parkinsons disease, patient engagement, patient input, Patient Voice, patients, Patients as Partners Europe, Pfizer, pharma, Pharmaceutical, Pierre Fabre, Regeneron, Takeda, UCB
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?